Portal de Periódicos da CAPES

Erythema of the proximal nailfold in HIV-infected patients

1996; Elsevier BV; Volume: 35; Issue: 4 Linguagem: Inglês

10.1016/s0190-9622(96)90694-5

1097-6787

Peter Itin, L. Gilli, Reto Nüesch, S. Courvoisier, Manuel Battegay, Theo Rufli, Paul J. Gasser,

Eosinophilic Disorders and Syndromes

11. Weisbart RH, Gasson JC, Golde DW. Colony-stimulating factors and host defense. Ann Intern Med 1989;110:297303. 12. Samlaska CP, Noyes DK. Localized cutaneous reactions to granulocyte colony-stimulating factor. Arch Dermatol 1993; 129:645-6. 13. Mehregan DR, Fransway AF, Edmonson JH, et al. Cutaneous reactions to granulocyte-monocyte colony-sfirnulating factor. Arch Dermatol 1992; 128:1055-9. 14. Horn TD, Burke PJ, Karp JE, et al. Intravenous administration of recombinant human granulocyte-macrophage colony stimulating factor causes a cutaneous eruption. Arch Dermatol 1991;127:49-52. 15. Farmer KL, Kurzrock R, Gutterman JU, et al. Necrotizing vasculitis at granulocyte-macrophage colony-stimulating factor injection sites. Arch Dermatol 1990;126:1243-4. 16. Negrin RS, Heuber DH, Nagler A, et al. Treatment of myelodysplastic syndromes with recombinant human granulocyte-colony stimulating factor. Ann Intern Med 1989; 110:976-84. 17. Kelly R, Marsden RA, Bevan D. Exacerbation of psoriasis with GM-CSF therapy. Br J Dermatol 1993;128:468-9. 18. Dreicer R, Schiller JI-t, Carbone PP. Granulocyte-macrophage colony-stimulating factor and vasculitis. Ann Intern Med 1989; 111:91-2. 19. Jain KK. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994;31: 213-5. 20. Wodzinski MA, Hampton KK, Reilly JT. Differential effect of G-CSF and GM-CSF in acquired chronic neutropeIlia. Br J Haematol 1991;77:249-50. 21. Kluin-Nelemans JC, Hollander AAM, Fibbe WE, et al. Leukocytoclastic vasculitis during GM-CSF therapy. Br J Haematol 1989;73:419-20. 22. Ross HJ, Moy LA, Kaplan R, et al. Bullous pyoderma gangrenosum after granulocyte colony stimulating factor treatment. Cancer 1991;68:441-3. 23. Park JW, Mehrotra B, Barnett BO, et al. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med 1992;116:996-8. 24. Glaspy JA, Baldwin GC, Robertson PA, et al. Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony stimulating factor. Ann Intern Med 1988;109:789-95. 25. Morioka N, Otsuka T, Nogita T, et al. Neutrophilic dermatosis with myelodysplastic syndrome: nuclear segmentation anomalies of neutrophils in the skin lesion and in peripheral Mood. J Am Acad Dermatol 1990;23: 247-9. 26. Sweet RD. An acute febrile neutrophillc dermatosis. Br J Dermatol 1964;76:349-59. 27. von den Driesch P. Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31:53556. 28. Piette WW, Trapp JF, O'Donnell MJ, et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-refinoic acid therapy. J Am Acad Dermatol 1994;30:293-7.